Medicine and Dentistry
T Cell
80%
Chimeric Antigen Receptor
57%
Chimeric Antigen Receptor T-Cell
48%
Cells
39%
Immunotherapy
36%
Solid Malignant Neoplasm
34%
Neoplasm
33%
Malignant Neoplasm
28%
Patient
24%
Receptor
23%
Chimeric Antigen Receptor T-Cell Immunotherapy
23%
Cancer
20%
Disease
19%
Alendronic Acid
19%
Therapeutic Procedure
18%
Positron Emission Tomography
18%
ErbB
16%
Regulatory T Cell
15%
Adoptive Immunotherapy
14%
Ligand
13%
Enalapril Maleate
13%
Combination Therapy
12%
Mucin 1
12%
Integrin
11%
Mesothelioma
11%
Obstetric Delivery
11%
Toxicity
11%
Krukenberg Tumor
10%
B Cell
10%
Cell Therapy
10%
Ex Vivo
10%
Antigen
9%
Human
9%
In Vitro
9%
Cancer Immunotherapy
8%
Reagent
8%
Interleukin 4
8%
T Lymphocyte Receptor
7%
Inpatient
7%
Antigen Specificity
7%
Chimeric Antigen Receptor T-Cell Therapy
7%
Iodine 124
7%
Infection
7%
Single-Photon Emission Computed Tomography
7%
Tenidap
6%
Xenograft
6%
Hematologic Malignancy
6%
Blood
6%
Antibody
6%
Gene Transfer
6%
Immunology and Microbiology
Chimeric Antigen Receptor
62%
Chimeric Antigen Receptor T-Cell
57%
Immunotherapy
44%
Solid
32%
Cells
27%
MUC1
22%
Development
20%
CD28
17%
Adoptive Immunotherapy
17%
Macrophage Colony-Stimulating Factor
13%
Immunity
13%
Cancer Immunotherapy
13%
Cytokine
12%
Chimeric Antigen Receptor T-Cell Therapy
11%
Regulatory T Cell
11%
Tumor Cell
11%
Membrane
9%
Co-Stimulation
9%
Breast
8%
Interleukin 4
8%
Monospecific Antibody
8%
CD19
8%
Electric Potential
7%
Tumor Antigen
7%
Single Photon Emission Computed Tomography
7%
Positron Emission Tomography
7%
Mutant
7%
Cell Differentiation
7%
Cytotoxic T Cell
7%
T Cell Receptor
7%
NKG2D
7%
Time
7%
Growth
7%
Immunology
6%
Gene
6%
Cell Surface
5%
Myeloid
5%
Cytokine Receptor
5%
Prostate Specific Membrane Antigen
5%
Gene Transfer
5%
Regulatory Mechanism
5%
Immune System
5%
SCID Beige Mouse
5%
Antineoplastic Activity
5%
Antigen
5%
B Cell
5%
Cancer Cell
5%
Natural Killer Cell
5%
Evolution
5%
Cell Activation
5%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Chimeric Antigen Receptor
89%
Solid
29%
MUC1
22%
ErbB
20%
Development
16%
Interleukin 4
12%
Antibody
11%
Integrin
11%
CD28
10%
Clinical Trial
9%
Cancer Immunotherapy
9%
CD19
7%
Antineoplastic Activity
7%
Evolution
7%
T Cell Receptor
7%
Membrane
7%
Monoclonal Antibody
6%
Mouse
5%
Molecule
5%
Regulatory Mechanism
5%
Human
5%
Electric Potential
5%